Scientists and researchers are working round-the-clock to find a safe, effective and affordable vaccine against Covid-19.
Meanwhile, China has granted the first invention patent to a domestic coronavirus vaccine candidate developed by CanSino Biologics.
As per reports, a coronavirus vaccine candidate developed by Chinese biopharmaceutical firm CanSino Biologics Inc has been granted the country first invention patent.
The vaccine is named as Ad5-nCoV and experts claimed demonstrates its originality and creativity. According to a document published, the vaccine can start mass production in a short time period in case of an outbreak.
Meanwhile, China has granted the first invention patent to a domestic coronavirus vaccine candidate developed by CanSino Biologics.
As per reports, a coronavirus vaccine candidate developed by Chinese biopharmaceutical firm CanSino Biologics Inc has been granted the country first invention patent.
The vaccine is named as Ad5-nCoV and experts claimed demonstrates its originality and creativity. According to a document published, the vaccine can start mass production in a short time period in case of an outbreak.